Your session is about to expire
← Back to Search
Medication-Assisted Therapies for Opioid Use Disorder (ExMAT CA Trial)
ExMAT CA Trial Summary
This trial will study the best way to rapidly scale-up opioid agonist therapies in Central Asia to prevent HIV infections in people who inject drugs and their partners.
ExMAT CA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ExMAT CA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The study involves a survey that asks questions about injection drug use.I am over 18 and authorized to work at an opioid treatment program.I am 18 or older with opioid dependence, new to treatment or on treatment for less than 90 days.I am over 18 and a Chief Narcologist at an Oblast level.I am 18 years old or older.I am over 18 and work in opioid addiction treatment.I am over 18 and work in opioid addiction treatment.I am 18 or older, have opioid dependence, and am new to or have been on opioid addiction treatment for less than 90 days.I am 18 or older, have opioid dependence, and have never been on OAT or haven't been for over a year.The study is specifically looking for people who inject drugs and are receiving opioid agonist therapy.You meet the criteria for opioid addiction as defined in the DSM-V.This screening is only for people who inject drugs and are not currently on opioid agonist therapy.You have been diagnosed with an addiction to opioid drugs according to the DSM-V criteria.
- Group 1: NIATx Model
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment currently underway for this experiment?
"According to clinicaltrials.gov, this particular medical trial is not presently accepting candidates for participation. Having first been published on January 1st 2023 and last edited October 10th 2022, the study has yet to resume recruitment efforts. However, there are currently 292 other studies actively recruiting patients right now."
What is the ultimate aim of this clinical trial?
"This medical study will have a 36 month duration, during which the primary outcome of interest is OAT Census per Oblast. Other secondary outcomes include New Patients (being Total number of newly enrolled patients into OAT services, per country), Dropout per Oblast (Total number of patients dropping out of OAT services, per oblast) and New Patients Per Oblast (Total number of newly enrolled patients into OAT services, per oblast)."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger